Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part I.
Becker
R C
RC
Division of Cardiovascular Medicine, University of Massachusetts Medical Center, Worcester.
Corrao
J M
JM
Harrington
R
R
Ball
S P
SP
Gore
J M
JM
D000368:Aged; D000595:Amino Acid Sequence; D015906:Angioplasty, Balloon, Coronary; D003131:Combined Modality Therapy; D005342:Fibrinolysis / Q000187:drug effects; D006470:Hemorrhage / Q000139:chemically induced; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D008969:Molecular Sequence Data; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D015425:Myocardial Reperfusion; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016277:Ventricular Function, Left / Q000187:drug effects
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator